Evidence map›Paper›PMID 39215796›Full record

ArticleBiomolecular NMR assignments2024

Solution NMR backbone assignment of the N-terminal tandem Zα1-Zα2 domains of Z-DNA binding protein 1.

Lily G Beck, Jeffrey B Krall, Parker J Nichols, Quentin Vicens, Morkos A Henen, Beat Vögeli

Abstract read
In one paragraph

Article in Biomolecular NMR assignments, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Cromolyn as a novel pharmacophore of the Zα domain of the RNA-editing enzyme ADAR1p150.Protein science : a publication of the Protein Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lily G BeckDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Jeffrey B KrallDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Parker J NicholsDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Quentin VicensDepartment of Biology and Biochemistry, Center for Nuclear Receptors and Cell Signaling, University of Houston, Houston, TX, 77204, USA.
Morkos A HenenDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Beat VögeliDepartment of Biochemistry and Molecular Genetics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. beat.vogeli@cuanschutz.edu.

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Molecular recognition by ADAR1 of Z-RNA within transcriptomesR01GM150642 · NIGMS · UNIVERSITY OF HOUSTON · PI Quentin Vicens, Beat Rolf Vogeli · 2023 to 2026
$1.2M
600 MHz NMR console and cold probeS10OD025020 · OD · UNIVERSITY OF COLORADO DENVER · PI JONES, DAVID NIGEL · 2018 to 2018
$501k
Small molecule inhibitors targeting the SARS-CoV-2 pathogenicity factor Nsp1R21AI171827 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HENEN, MORKOS, STECKELBERG, ANNA-LENA · 2022 to 2023
$458k
A-Z junction formation drives recognition of Alu RNAs by ADAR1 and supports viral infectivity and replicationF31AI167396 · NIAID · UNIVERSITY OF COLORADO DENVER · PI NICHOLS, PARKER J · 2022 to 2024
$109k
NCI NIH HHS P30 CA046934NIAID NIH HHS F31 AI167396NIAID NIH HHS R21 AI171827NIGMS NIH HHS R01 GM150642NIH HHS F31AI167396NIH HHS R01 GM150642NIH HHS R21 AI171827NIH HHS S10 OD025020
6 · The paper itself

Abstract

The detection of nucleic acids that are present in atypical conformations is a crucial trigger of the innate immune response. Human Z-DNA binding protein 1 (ZBP1) is a pattern recognition receptor that harbors two Zα domains that recognize Z-DNA and Z-RNA. ZBP1 detects this alternate nucleic acid conformation as foreign, and upon stabilization of these substrates, it triggers activation of an immune response. Here, we present the backbone chemical shift assignment of a construct encompassing the Zα1 and Zα2 domains as well as the interconnecting linker of ZBP1. These assignments can be directly transferred to the isolated Zα1 and Zα2 domains, thereby demonstrating that these domains maintain virtually identical structures in the tandem context.

Indexed as

DNA-Binding ProteinsNuclear Magnetic Resonance, BiomolecularProtein DomainsHumansRNA-Binding ProteinsSolutionsDNA-Binding ProteinsRNA-Binding ProteinsSolutionsZBP1 protein, humanBackbone chemical shift assignmentProtein structure and dynamicsZBP1Z-nucleic acidsZα domains

Identifiers

PMID39215796
PMCPMC12094057

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.